Timing of Endoscopy in Cirrhotic Patients with Acute Variceal Bleeding
NCT ID: NCT06031402
Last Updated: 2025-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
368 participants
INTERVENTIONAL
2024-09-04
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis
NCT04957875
The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis
NCT04932200
Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT
NCT04786743
Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding
NCT06214234
Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding
NCT05624229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early endoscopy group
Intervention of endoscopy is within 12 hours after admission
Endoscopy
Endoscopy
Delayed endoscopy group
Intervention of endoscopy is within 12-24 hours after admission
Endoscopy
Endoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopy
Endoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. patients with a diagnosis of liver cirrhosis based on imaging and pathology;
3. patients and/or their relatives who sign informed consents;
4. patients' age ≥18 years.
Exclusion Criteria
2. patients' hemodynamics are unstable after resuscitation;
3. patients with severe cardiovascular or cerebrovascular diseases or renal injury;
4. patients who have taken anticoagulants or antiplatelet drugs within 2 weeks before admissions, or are diagnosed with severe hematological diseases;
5. patients with human immunodeficiency virus or other acquired or congenital immune deficiency diseases;
6. patients with mental illness;
7. pregnancy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital of Shenyang Military Region
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xingshun Qi
Director of Department of Gastroenterology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xingshun Qi, MD
Role: PRINCIPAL_INVESTIGATOR
General Hospital of Shenyang Military Area
Yiling Li, MD
Role: PRINCIPAL_INVESTIGATOR
First Hospital of China Medical University
Bimin Li, MD
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital of Nanchang University
Xuefeng Luo, MD
Role: PRINCIPAL_INVESTIGATOR
West China Hospital
Xiaofeng Liu, MD
Role: PRINCIPAL_INVESTIGATOR
The 960th Hospital of the Chinese People's Liberation Army
Chunqing Zhang, MD
Role: PRINCIPAL_INVESTIGATOR
Affiliated Provincial Hospital of Shandong First Medical University
Mingkai Chen, MD
Role: PRINCIPAL_INVESTIGATOR
People's Hospital of Wuhan University
Derun Kong, MD
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital of Anhui Medical University
Fernando G Romeiro, MD
Role: PRINCIPAL_INVESTIGATOR
Botucatu Medical School
Andrea Mancuso, MD
Role: PRINCIPAL_INVESTIGATOR
Azienda di Rilievo Nazionale ad Alta Specializzazione Civico-Di Cristina-Benfratelli
Nahum Méndez-Sánchez, MD
Role: PRINCIPAL_INVESTIGATOR
Medica Sur Clinic and Foundation
Enqiang Linghu, MD
Role: PRINCIPAL_INVESTIGATOR
The First Medical Center of Chinese PLA General Hospital
Yunhai Wu, MD
Role: PRINCIPAL_INVESTIGATOR
The Sixth People's Hospital of Shenyang
Metin Basaranoglu, MD
Role: PRINCIPAL_INVESTIGATOR
Bezmialem Vakif University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Bai Z, Wang R, Cheng G, Ma D, Ibrahim M, Chawla S, Qi X. Outcomes of early versus delayed endoscopy in cirrhotic patients with acute variceal bleeding: a systematic review with meta-analysis. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e868-e876. doi: 10.1097/MEG.0000000000002282.
Peng Y, Qi X, Dai J, Li H, Guo X. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med. 2015 Jan 15;8(1):751-7. eCollection 2015.
Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore). 2016 Feb;95(8):e2877. doi: 10.1097/MD.0000000000002877.
Li Y, Li H, Zhu Q, Tsochatzis E, Wang R, Guo X, Qi X. Effect of acute upper gastrointestinal bleeding manifestations at admission on the in-hospital outcomes of liver cirrhosis: hematemesis versus melena without hematemesis. Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1334-1341. doi: 10.1097/MEG.0000000000001524.
Qi X, Li Y, Li B, Luo X, Liu X, Zhang C, Chen M, Kong D, Wu Y, Romeiro FG, Basaranoglu M, Zhang J, Li Q, Wang R, Shao X, Guan L, Wang N, You Y, He M, Wang X, Huang J, Wu W, Li Q, Zhang M, Wang G, Zhang C, Cheng D, Zhang Q, Mei X, Sun N, Ban Y, Marcondes MB, Yamashiro FDS, Mutlu E, Zheng Z, Peng M, Xu W, Li Z, Chai L, Linghu E. Timing of endoscopy in cirrhotic patients with acute variceal bleeding: protocol of a multicenter randomized controlled trial. Therap Adv Gastroenterol. 2024 Nov 13;17:17562848241295452. doi: 10.1177/17562848241295452. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XHNKKY-ENDO-AVB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.